Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Boehringer Ingelheim
Fish and Richardson
US Army
Daiichi Sankyo
Express Scripts

Generated: September 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040145

« Back to Dashboard
NDA 040145 describes WARFARIN SODIUM, which is a drug marketed by Taro Pharm, Amneal Pharms, Ipca Labs Ltd, Mylan, Pliva, Watson Labs, Usl Pharma, Invagen Pharms, Barr, Zydus Pharms Usa, and Sandoz, and is included in seventeen NDAs. It is available from thirty-four suppliers. Additional details are available on the WARFARIN SODIUM profile page.

The generic ingredient in WARFARIN SODIUM is warfarin sodium. There are twenty-two drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the warfarin sodium profile page.

Summary for NDA: 040145

Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details

Pharmacology for NDA: 040145

Mechanism of ActionVitamin K Inhibitors

Suppliers and Packaging for NDA: 040145

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
warfarin sodium
TABLET;ORAL 040145 ANDA Teva Pharmaceuticals USA, Inc. 0555-0831 0555-0831-02 100 TABLET in 1 BOTTLE (0555-0831-02)
warfarin sodium
TABLET;ORAL 040145 ANDA Teva Pharmaceuticals USA, Inc. 0555-0831 0555-0831-05 1000 TABLET in 1 BOTTLE (0555-0831-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Mar 26, 1997TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Mar 26, 1997TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Mar 26, 1997TE:ABRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Farmers Insurance
Harvard Business School
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus